CLINICAL PHARMACY, PHARMACEUTICAL CARE, AND THE QUALITY OF DRUG THERAPY

Main Article Content

Mohammed Salah AL-Kastban
Ibrahim Salah AL-Kastban
Saud Salah Alkastban
Nasser Hassen Wutayd
Ali Saeed Harboosh Al Alharth
Yahya Abdulhadi Moreh al regheeb
Hassan Salem Hassan Al-munyif
Naser Faraj Al-yami
Nasser Salem Soman Al_Salem

Keywords

clinical pharmacy, pharmaceutical care, medications use systems.

Abstract

Background. Because of concerns about patient safety and the quality of health care in America, in particular about drug therapy, pharmacists have unprecedented opportunities to increase their value and significance. When defining clinical pharmacy and pharmaceutical care, pharmacists long ago recognized the need to improve the safety and effectiveness of drug therapy.


 


Objective. To describe how clinical pharmacy and pharmaceutical care, closely related concepts, can contribute to a strategy for improving the quality of drug therapy.


 


Design. Commentary and review of selected publications.


 


Conclusion. Pharmacists can improve the quality of drug therapy by improving the organizational structures through which drug therapy is provided, specifically by creating medications use systems and by regularly evaluating their performance. As envisaged by the Institute of Medicine, these systems must be patient centered, cooperative, and interprofessional. To maximize pharmacists’ participation in such systems, pharmaceutical education should include courses in medications use systems as necessary counterparts to courses in pharmacotherapeutics. Clinical functions must be organized around patient need and directed at outcomes. Clinical practice should constitute the mainstream practice of pharmacy rather than an “optional” specialty.   Pharmaceutical care describes the original purpose of clinical pharmacy, when it was understood as a professional practice rather than a health science. It describes a way that clinical pharmacy, especially specialists and subspecialists, could coordinate their work more effectively. The concept of clinical pharmacy adds essential clarity about the process component of pharmacists’ participation in, and strengthens the academic basis of, pharmaceutical care. The clinical, humanitarian, and economic case for preventing drug-related morbidity is strong, and pharmacy has much to offer. It is, again, time to work together as a profession to plan our common future. 

Abstract 157 | PDF Downloads 156

References

1. Kohn LT, Corrigan JT, Donaldson MS. To err is human: building a safer health system. Washington, DC: National Academy Press, 1999.
2. Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington, D.C.: National Academy Press, 2001.
3. Berwick DM. A user’s manual for the IOM’s quality chasm report. Health Aff (Millwood) 2002;21:80–90.
4. Brodie DC, Parish PA, Poston JW. Societal needs for drugs and drug related services. Am J Pharm Ed 1980;44:276–8.
5. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Pharm Ed 1989;53(suppl):S7–15.
6. Parish PA. What future for pharmacy practice? Pharm J 1985;234:209–11.
7. Hepler CD. The third wave in pharmaceutical education: the clinical movement. Am J Pharm Ed 1987;51:369–85.
8. Brushwood DB, Hepler CD. Redefining pharmacist professional responsibility. In: Knowlton CH, Penna RP, eds. Pharmaceutical care. New York: Chapman & Hall, 1996: 195–214.
9. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill, 1998:1.
10. Office of the Inspector General. The clinical role of the community pharmacist. Washington, DC: U.S. Department of Health and Human Services, November 1990.
11. Hepler CD, Segal R. Preventing medication errors and improving drug therapy outcomes through system management. Boca Raton, FL: CRC Press, 2003.
12. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289:1107–16.
13. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med 2003;348:1556–64.
14. Hepler CD. Perspectives from research in the social and behavioral sciences. Am J Hosp Pharm 1986;43:2759–63.
15. Hepler CD. Regulating for outcomes as a systems response to the problem of drug-related morbidity. J Am Pharm Assoc 2001;41:108–15.
16. Hepler CD. Observations on the conference: a pharmacist’s perspective. Am J Health-Syst Pharm 2000;57:590–4.
17. Hepler CD. The impact of pharmacy specialities on the profession and the public. Am J Hosp Pharm 1991;48:487–500.